CCL5 is associated with poor prognosis in locally advanced pancreatic cancer (LAPC): biomarker analysis from the randomised phase II SCALOP trial

Willenbrock F., Cox C., Wilhelm-benartzic C., Owens R., Sabbagh A., Abraham A., Maughan T., Hurt C., O'Neill E., Mukherjee S.

Type

Conference paper

Publication Date

07/2019

Volume

30

Pages

110 - 110

Permalink